SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending following a significant $816 million contract award to build 18 missile-defense satellites for the U.S. Space Force, marking its largest deal to date. This substantial win has fueled intense community discussion about its growing role in the space and defense sector, with many anticipating further upside from upcoming catalysts like the Neutron rocket and the broader momentum in space stocks. Sentiment suggests strong conviction that this contract validates Rocket Lab's position alongside larger prime contractors and could trigger short-covering activity.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as political discourse intensifies around healthcare costs, with public statements calling for insurance companies to reduce prices. The community is actively debating the potential for a market impact, with some anticipating declines for the sector while others view the rhetoric as political maneuvering that could still lead to long-term benefits for diversified players like UNH. Additional discussions include the potential implications of ongoing talks about ACA subsidies and the company's recently adopted operational improvements following independent audits.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending due to a positive analyst rating from KeyBanc and mounting anticipation for a key NASA Lunar Terrain Vehicle (LTV) contract award. The community is actively discussing the potential for a short squeeze, viewing LUNR as a front-runner in the heating up space exploration sector. This sentiment, bolstered by broader governmental focus on American space superiority, is driving significant trading volume.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing a strong rally, largely attributed to its selection for a U.S. Department of Energy initiative and a renewed 'Buy' rating from analysts. The community is actively discussing a massive short squeeze, with many expressing strong bullish conviction about its strategic importance in the rapidly expanding AI infrastructure sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its proposed merger with a nuclear fusion company, dramatically shifting its business focus into the speculative energy sector. This pivot is driving intense debate among investors, with supporters touting it as a visionary move for energy independence and significant future growth, while skeptics warn of substantial dilution and question the viability of merging a social media platform with a pre-revenue technology venture. The discussion is further amplified by broader political discourse, contributing to high volatility and strong polarization in community sentiment surrounding the stock.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is experiencing heightened trading activity and surging volume, propelled by a significant new contract for spacecraft docking systems and its pivotal role in critical space infrastructure. The community is buzzing with optimism about the company's prospects in the expanding space economy, driven by narratives around in-space data centers, defense initiatives, and potential short-squeeze dynamics.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community eagerly anticipates confirmed ISO 20022 compliance and the launch of its Super App, alongside recent strategic partnerships with entities like NatPay, Fasset, and Dash. Discussions highlight Zebec's foundational work in real-time compliant payments, leading many to accumulate and stake tokens. This robust development in payment infrastructure and global utility is driving comparison to established compliant digital assets, with community members expressing strong conviction for significant long-term growth despite observed market fluctuations.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending on strong bullish sentiment driven by the imminent BlueBird 6 satellite launch and anticipation of an expedited launch schedule, with multiple subsequent launches planned. The community is also highly focused on the recent signing of the Golden Dome defense bill, which is expected to unlock significant government contracts for commercial space solutions and is seen as a major catalyst for the company and the broader space sector.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is trending with intense trading activity, driven by a recent analyst "buy" rating and an upcoming special cash dividend. Community discussion is focused on the company's hinted pivot towards blockchain-based assets and its historically high short interest, contributing to significant volatility and mixed sentiment.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is trending following the FDA approval of MYQORZO (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy, a groundbreaking treatment that has ignited significant community discussion. Investors are highlighting its favorable REMS program and differentiated profile compared to existing therapies, positioning it as a potential new standard of care in the sector. This pivotal regulatory milestone continues to fuel ongoing speculation regarding potential future acquisition interest in the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. stock markets spiraled lower last week as President Donald Trump's sweeping reciprocal tariffs rattled global investors.&nbsp;But while tech and industrials bore the brunt of the selloff, healthcare stocks showed surprising resilience — living up to their reputation as a defensive haven during periods of economic uncertainty.Here are three names from the sector that stood out&nbsp;with staggering weekly gains, offering retail traders on Stocktwits a rare dose of optimism in an otherwise chaotic week:iCoreConnect Inc (ICCT) - 1,579% weekly gain&nbsp;Ocoee, Florida-based iCoreConnect offers software-as-a-service for the healthcare market. Last week, there were no major news catalysts for the stock, although it has seen heavy trading volume since the beginning of April.&nbsp;On Stocktwits, sentiment remained 'extremely bullish' last week amid stunning gains, with followers jumping by 69% and message volume exploding by over 40,400%.&nbsp; &nbsp;<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/ICCT_sentiment_and_message_volume_as_of_April_6_png_16855887e8.webp" alt="ICCT sentiment and message volume as of April 6.png" width="1318" height="316"><figcaption>ICCT sentiment and message volume as of April 6. | source: Stocktwits</figcaption></figure>Recent posts suggest that retail traders anticipate a major development, though many dismissed the possibility of another equity offering —something the company has done multiple times.Last year, the company received the backing of several state dental associations for its cloud solutions and made some strategic acquisitions.BioAffinity Technologies Inc (BIAF) - 163% weekly gain&nbsp;San Antonio, Texas-based BioAffinity is a company focused on making products for the early detection of cancers. Its initial product, CyPath Lung, uses a patient's sputum and proprietary automated flow cytometry data analysis to diagnose early-stage lung cancer accurately.Last week, Maxim — the sole research firm covering the stock — downgraded BioAffinity to 'Hold' from 'Buy' after the company posted annual financial results.BioAffinity's 2024 revenue increased 270% from a year earlier, primarily due to the acquisition of Precision Pathology Laboratory Services (PPLS). However, the company's net loss also increased due to higher operating expenses.In March, BioAffinity said it expects to realize most of its planned $4 million in annual cost savings through workforce and operational cuts at PPLS and improving operational efficiency by cutting supply and service costs.&nbsp;<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/BIAF_sentiment_and_message_volume_as_of_April_6_png_0a9f433739.webp" alt="BIAF sentiment and message volume as of April 6.png" width="1318" height="316"><figcaption>BIAF sentiment and message volume as of April 6. | source: Stocktwits</figcaption></figure>On Stocktwits, sentiment ended Friday higher in the 'extremely bullish' zone amid a 3,750% spike in weekly message volume.Alaunos Therapeutics Inc (TCRT) - 102% weekly gain&nbsp;Houston, Texas-based Alaunos is a biotech firm that also rocketed last week with virtually no major news catalysts, with Stocktwits sentiment flipping to 'extremely bullish' from 'neutral.'&nbsp;Regulatory filings from April 1 revealed that senior executives, including interim CEO Dale Curtis Hogue, exercised options to buy 7,000 shares at $1.46 apiece.&nbsp;The company's annual 10-K report also showed that Alaunos' 2024 revenue doubled to $10,000, while net loss shrank to $4.6 million from $35.1 million a year earlier.&nbsp;Alaunos significantly cut expenses by winding down clinical programs, such as its costly TCR-T clinical trial, and reducing headcount.&nbsp;The company is exploring strategic options such as mergers, partnerships, or asset sales.&nbsp;<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/TCRT_sentiment_and_message_volume_as_of_April_6_png_163e68145a.webp" alt="TCRT sentiment and message volume as of April 6.png" width="1318" height="316"><figcaption>TCRT sentiment and message volume as of April 6. | source: Stocktwits</figcaption></figure>Alaunos is now focused on its small molecule oral obesity drug program, which aims to offer a differentiated alternative to injectable GLP-1 therapies by preserving lean muscle mass.&nbsp;Alaunos regained Nasdaq compliance in February and expects its current cash reserves to last into the second quarter.For updates and corrections, email newsroom[at]stocktwits[dot]com.

These 3 Healthcare Stocks Show Serious Muscle Amid Trump Tariff Turmoil: Are Retail Traders Feeling Bullish?

iCoreConnect, BioAffinity and Alaunos Therapeutics posted strong gains last week amid heavy trading volume.

Equity

iCoreConnect, BioAffinity and Alaunos Therapeutics posted strong gains last week amid heavy trading volume.


iCoreConnect, Inc. engages in the provision of cloud-based software and technology. It is focused on increasing workflow productivity and customer profitability through its enterprise platform of application and services. The company was founded in 1992 and is headquartered in Ocoee, FL.

Current Price	$0.001
Prev Close	$0.0012
Open	$0.001
Dividend Yield	0.00%
50-Day Moving Average	$0.004
Beta	2.67
Avg. Volume	7,028.00
PE Ratio	0.00

52-Week High	$8.20
52-Week Low	$0.0001
Market Capitalization	$5,852.00
EPS (Annual)	-$45.78
Price to Book	-0.00
Revenue Per Employee	$149,256.47
Enterprise Value/EBITDA	N/A

ICCT
iCoreConnect Inc

Feed

News

Sentiment

Fundamentals

Info

Latest ICCT News

ICCTiCoreConnect Inc